State Street Corporation 13D and 13G filings for Kymera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 10:31 am Sale |
2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
STATE STREET CORP STT |
1,894,279 3.410% |
-951,942 (-33.45%) |
Filing |
| 2023-02-08 2:16 pm Purchase |
2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
STATE STREET CORP STT |
2,846,221 5.190% |
2,846,221 (New Position) |
Filing |